$5.42
0.05[0.93%]
Last update: 9:50AM Get Real Time Here
Amneal Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Amneal Pharmaceuticals using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/03/2024 | AM | AMRX | Q1 | $0.12 | — | — | — | $557.54M | — | — | — | Get Alert |
03/01/2024 | AM | AMRX | Q4 | $0.23 | $0.09 | $0.14 | 55.56% | $609.76M | $634.23M | $616.98M | -2.72% | Get Alert |
11/07/2023 | AM | AMRX | Q3 | $0.14 | $0.13 | $0.19 | 46.15% | $545.56M | $595.27M | $620.04M | 4.16% | Get Alert |
08/04/2023 | AM | AMRX | Q2 | $0.19 | $0.10 | $0.19 | 90.00% | $559.36M | $562.49M | $599.05M | 6.50% | Get Alert |
05/05/2023 | AM | AMRX | Q1 | $0.12 | $0.10 | $0.12 | 20.00% | $497.63M | $537.31M | $557.54M | 3.77% | Get Alert |
03/02/2023 | AM | AMRX | Q4 | $0.17 | $0.21 | $0.23 | 9.52% | $536.90M | $579.91M | $609.76M | 5.15% | Get Alert |
11/04/2022 | AM | AMRX | Q3 | $0.21 | $0.18 | $0.14 | -22.22% | $528.59M | $564.15M | $545.56M | -3.30% | Get Alert |
08/05/2022 | AM | AMRX | Q2 | $0.25 | $0.20 | $0.19 | -5.00% | $535.08M | $536.34M | $559.36M | 4.29% | Get Alert |
05/04/2022 | AM | AMRX | Q1 | $0.20 | $0.13 | $0.12 | -7.69% | $493.11M | $503.97M | $497.63M | -1.26% | Get Alert |
03/02/2022 | AM | AMRX | Q4 | $0.14 | $0.20 | $0.18 | -10.00% | $510.03M | $537.35M | $536.90M | -0.08% | Get Alert |
11/03/2021 | AM | AMRX | Q3 | $0.16 | $0.20 | $0.21 | 5.00% | $519.29M | $545.06M | $528.59M | -3.02% | Get Alert |
08/09/2021 | AM | AMRX | Q2 | $0.13 | $0.19 | $0.25 | 31.58% | $464.66M | $523.25M | $535.08M | 2.26% | Get Alert |
05/07/2021 | AM | AMRX | Q1 | $0.20 | $0.18 | $0.20 | 11.11% | $498.53M | $515.34M | $493.11M | -4.31% | Get Alert |
02/26/2021 | AM | AMRX | Q4 | $0.08 | $0.13 | $0.14 | 7.69% | $397.33M | $507.02M | $510.03M | 0.59% | Get Alert |
11/06/2020 | AM | AMRX | Q3 | $0.04 | $0.12 | $0.16 | 33.33% | $378.28M | $482.11M | $519.29M | 7.71% | Get Alert |
08/06/2020 | AM | AMRX | Q2 | $0.09 | $0.10 | $0.13 | 30.00% | $404.64M | $458.44M | $464.66M | 1.36% | Get Alert |
05/11/2020 | AM | AMRX | Q1 | $0.14 | $0.09 | $0.20 | 122.22% | $446.12M | $444.23M | $498.53M | 12.22% | Get Alert |
02/26/2020 | AM | AMRX | Q4 | $0.33 | $0.05 | $0.08 | 60.00% | $497.53M | $394.78M | $397.33M | 0.65% | Get Alert |
11/06/2019 | AM | AMRX | Q3 | $0.28 | $0.14 | $0.04 | -71.43% | $476.49M | $410.98M | $378.28M | -7.96% | Get Alert |
Amneal Pharmaceuticals (AMRX) is scheduled to report earnings on May 3, 2024. The last reported earnings were for reported on March 1, 2024 for Q4.
The Actual EPS was $0.14, which beat the estimate of $0.09.
The Actual Revenue was $617M, which missed the estimate of $634.2M.
Browse earnings estimates, EPS, and revenue on all stocks.